Pages that link to "Item:Q2492921"
From MaRDI portal
The following pages link to Adaptive designs for dose-finding based on efficacy-toxicity response (Q2492921):
Displaying 37 items.
- Dose-Finding Based on Efficacy-Toxicity Trade-Offs (Q70261) (← links)
- Optimal designs for contingent response models with application to toxicity-efficacy studies (Q389259) (← links)
- Elemental information matrices and optimal experimental design for generalized regression models (Q389421) (← links)
- Information in a two-stage adaptive optimal design (Q389442) (← links)
- Adaptive optimal designs for dose-finding studies based on sigmoid \(E_{\max}\) models (Q389444) (← links)
- Robust designs for multivariate logistic regression (Q478485) (← links)
- Barycentric algorithm for computing D-optimal size- and cost-constrained designs of experiments (Q513974) (← links)
- Optimal designs for dose-finding experiments in toxicity studies (Q605849) (← links)
- Design of experiments for bivariate binary responses modelled by copula functions (Q901524) (← links)
- Penalized optimal designs for dose-finding (Q1036729) (← links)
- Asymptotic properties of nonlinear estimates in stochastic models with finite design space (Q1036746) (← links)
- Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials (Q1654244) (← links)
- One-step ahead adaptive \(D\)-optimal design on a finite design space is asymptotically optimal (Q2268376) (← links)
- Optimal design to discriminate between rival copula models for a bivariate binary response (Q2273148) (← links)
- Random norming AIDS analysis of non-linear regression models with sequential informative dose selection (Q2301071) (← links)
- On optimal designs for clinical trials: an updated review (Q2301225) (← links)
- Adaptive designs for drug combination informed by longitudinal model for the response (Q2423165) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Cumulative cohort design for dose-finding (Q2455719) (← links)
- Adaptive designs for selecting drug combinations based on efficacy-toxicity response (Q2475724) (← links)
- Optimal adaptive designs for acute oral toxicity assessment (Q2492920) (← links)
- A comparison of allocation strategies for optimising clinical trial designs under variance heterogeneity (Q2674509) (← links)
- Optimal designs for copula models (Q2953573) (← links)
- Incorporating Individual and Collective Ethics into Phase I Cancer Trial Designs (Q3013989) (← links)
- Sequential Methods in Multi-Arm Clinical Trials (Q3068083) (← links)
- Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpoint (Q3076087) (← links)
- A New Dose‐Finding Design for Bivariate Outcomes (Q3433237) (← links)
- Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios (Q3436524) (← links)
- Some Properties for a Simplified Cox Binary Model (Q3532750) (← links)
- (Q5072154) (← links)
- Simple benchmark for complex dose finding studies (Q5170208) (← links)
- Asymmetric Copulas and Their Application in Design of Experiments (Q5213717) (← links)
- On the combination of <i>c</i>‐ and <i>D</i>‐optimal designs: General approaches and applications in dose–response studies (Q5347419) (← links)
- Optimal designs for active controlled dose-finding trials with efficacy-toxicity outcomes (Q5384555) (← links)
- Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information (Q6085905) (← links)
- Combined criteria for dose optimisation in early phase clinical trials (Q6625215) (← links)
- Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimens (Q6628011) (← links)
